Cancer by Sfakianakis Alexandros: Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

Πέμπτη 7 Ιουλίου 2016

Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

To evaluate the use of high-dose radiotherapy using carbon ions (C12) on non-adenoid cystic malignant salivary gland tumors (MSGT).

from Cancer via ola Kala on Inoreader http://ift.tt/29oEtjw
via IFTTT

Πέμπτη 7 Ιουλίου 2016

Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου